engleski

First Outcomes of Anti-IL5 Biological Therapy in Patients with Severe Asthma in Croatia

Currently in Croatia, there are 275 severe asthma patients treated with biological therapy. Most of them (201) are receiving anti-IL5 therapy. To assess the outcomes of the most used biological therapy in severe asthma patients in Croatia, we conducted a real-life study, including 41 patients receiving anti-IL5 therapy at Clinical Center for Lung Diseases Jordanovac. Although our data offers some insight into biological therapeutics outcomes, we need a larger group of patients to make more precise conclusions.

Anti-IL5 ; Severe asthma

nije evidentirano